Movex® – joints and spine recovery on “turnkey” basis

Composition of active ingredients: 

1 tablet contains - glucosamine sulfate 500 mg,
chondroitin sulfate natrium 400 mg

Dosage form: 

Coated tablets in bottle №30, №60 and №120
in carton package

  • Efficiency and safety proven clinically*
  • Normalizes the restoration of joints and spine cartilage tissue
  • “Lubricates” joints surface and stimulates production of synovial fluid

Administration and Dosages

For adults: take 1 tablet 3 times a day during first three weeks, following days - 1-2 tablets 2 times per day for 3 months. during before or after meal. The course has to be repeated 2-3 times a year. On doctor’s prescription the treatment could be longer.

Pharmacotherapeutic group

Ingredients are applying for the musculoskeletal system treatment. Nonsteroid anti-inflammatory and antirheumatic drugs. АТС М01АХ

Pharmacological properties

Glucosamine is the substrate of cartilage construction and stimulates the regeneration of cartilage tissue. Glycosaminoglycans and proteoglycans are the part of a complicated matrix the cartilage composed of. Glucosamine is included as a compound of endogenous glycosaminoglycans of cartilage, stimulates the production of proteoglycans and increases the absorption of sulphate by articular cartilage. Therefore, glucosamine compensates the endogenous deficiency of glucosamine. It participates in the biosynthesis of proteoglycans and hyaluronic acid, consequently resist the progression of degenerative processes in the joints, the spine and surrounding soft tissues; It stimulates the production of chondroitin acids, normalizes calcium deposition in bone tissue, contributes to restoration of the articular function and disappearance of pain syndrome.

Chondroitin sulfate has a chondroprotective effect, stimulates the regeneration of cartilage tissue, exhibits the anti-inflammatory and analgesic effect. Chondroitin sulfate natrium, which affects the calcium-phosphorus metabolism in cartilage, is represented as a macromolecular mucopolysaccharide (m.m. 20000-30000). The drug slows the bone tissue resorption and reduces the calcium loss, slows the cartilage degeneration. . Prevents the compression of the connective tissue, “lubricates” the joint surfaces and normalizes the joint fluid production.

To obtain full information please see the Patient Leaflet Information.


Degenerative-dystrophic diseases of joints and spine:

  • primary and secondary osteoarthritis,
  • osteochondrosis,
  • humeroscapular periart,
  • fractures (to accelerate the formation of callus).


Individual hypersensitiveness to any of the medicine ingredients, phenylketonuria. Do not use in case of shellfish allergy.  

To obtain full information please see the Patient Leaflet Information.

The need for nonsteroidal anti-inflammatory medicines reduces during taking the Movex.

Do not exceed the recommended dose.

Do not take the medicine if you are pregnant or breast feeding.

To obtain full information please see the Patient Leaflet Information.

Store in the original package below +25°С.
Keep out of the reach of children.

R.S.  MOH  of  Ukraine №  UA/9817/01/01 of 26.04.2019